Synapse Open Synapse
Biology

STAT+: Vertex kidney disease drug scrutinized for infection risk

STAT News · · 1 min read

Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk.

Latest from STAT News